{"mainPropery":{"diseaseId":5761,"diseaseName":"Afibrinogenemia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5761/afibrinogenemia","synonyms":["Afibrinogenemia congenital","Congenital afibrinogenemia"],"synonyms-with-source":[{"name":"Afibrinogenemia congenital"},{"name":"Congenital afibrinogenemia"}],"identifiers":[{"identifierType":"OMIM","identifierId":"202400"},{"identifierType":"ORPHANET","identifierId":"98880"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"}],"organizations":[{"resourceID":461,"resourceName":"National Hemophilia Foundation","abbreviation":"","address1":"7 Penn Plaza, Suite 1204","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10001 ","country":"United States","phone":"+1-212-328-3700","tty":"","tollFree":"1-800-42-HANDI","fax":"+1-212-328-3777","email":"handi@hemophilia.org","url":"https://www.hemophilia.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/202400' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=202400' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Afibrinogenemia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Afibrinogenemia%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Afibrinogenemia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/congenital-afibrinogenemia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Afibrinogenemia. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0001733' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/940/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001313.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/960677-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98880' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:202400' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":2289,"questionText":"What is afibrinogenemia?","answerText":"<strong>Afibrinogenemia</strong>, sometimes called congenital afibrinogenemia, is an inherited blood disorder in which the blood does not <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001124.htm\" target=\"_blank\">clot</a> normally. It occurs when there is a lack (deficiency) of a protein called <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003650.htm\" target=\"_blank\">fibrinogen</a>&nbsp;(or coagulation factor I), which is needed for the blood to clot.[1413][1414]&nbsp;Affected individuals may be susceptible to severe bleeding (hemorrhaging) episodes, particularly during infancy and childhood. Afibrinogenemia is thought to be transmitted as an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> trait.[1414] Treatment may include cryoprecipitate (a blood product containing concentrated fibrinogen and other clotting factors), fibrinogen concentrates or plasma (the liquid portion of the blood which contains clotting factors).[1413]\r\n<p>&nbsp;</p>","dateModified":"2016-05-30T00:00:00"},"basicQuestions":[{"questionId":2290,"questionText":"What symptoms may be associated with afibrinogenemia?","answerText":"<p>In afibrinogenemia, with fibrinogen levels less than 0.1 g/L, bleeding abnormalities range from mild to severe. Bleeding from the umbilical cord just after birth frequently provides an early alert to the abnormality. Other symptoms include the following:[1413][1415] </p>\r\n<ul style=\"list-style-type: circle;\">\r\n    <li><a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003106.htm\" target=\"_blank\">Nosebleeds</a> that are difficult to stop </li>\r\n    <li>Bleeding in the mucus membranes</li>\r\n    <li>Bleeding in the joints </li>\r\n    <li><a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/007213.htm\" target=\"_blank\">Bruising</a> easily</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003133.htm\" target=\"_blank\">Gastrointestinal bleeding</a>\r\n    </li>\r\n    <li><a href=\"http://www.mayoclinic.org/diseases-conditions/menorrhagia/basics/definition/con-20021959?METHOD=print\" target=\"_blank\">Menorrhagia</a> and postpartum hemorrhage\r\n    </li>\r\n    <li>Heavy bleeding after injury or surgery</li>\r\n    <li>Spontaneous rupture of the spleen</li>\r\n    <li>Bleeding inside the skull (intracranial hemorrhage) - very rare</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001488.htm\" target=\"_blank\">Miscarriage</a></li>\r\n</ul>","dateModified":"2016-05-30T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1413,"authors":"Chen YB, Zieve D","articleTitle":"Congenital afibrinogenemia","bookWebsiteJournalTitle":"MedlinePlus","date":"January 27, 2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001313.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1415,"authors":"Acharya SS","articleTitle":"Inherited Abnormalities of Fibrinogen","bookWebsiteJournalTitle":"Medscape Reference","date":"November 18, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/960677-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2291,"questionText":"What causes afibrinogenemia?","answerText":"Afibrinogenemia is&nbsp;caused by a severe lack of&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003650.htm\" target=\"_blank\">fibrinogen</a>&nbsp;(coagulation factor I), a protein in the blood that is essential in the blood clotting (coagulation) process.[1413][1414][1415] This&nbsp;defect in&nbsp;fibrinogen synthesis&nbsp;can result from&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in&nbsp;one or another of the fibrinogen genes&nbsp;alpha&nbsp;(<a href=\"http://omim.org/entry/134820\" target=\"_blank\"><em>FGA</em></a>),&nbsp;beta&nbsp;(<a href=\"http://omim.org/entry/134830\" target=\"_blank\"><em>FGB</em></a>) or gamma (<a href=\"http://omim.org/entry/134850\" target=\"_blank\"><em>FGG</em></a>).[1415][1416] Each of these three genes provides instructions for making one part (subunit) of the fibrinogen protein. When an injury occurs, fibrinogen is converted to fibrin, the main protein in blood clots. Fibrin proteins attach to each other, forming a stable network that makes up the blood clot. If there is a mutation in the <em>FGA</em>, <em>FGB</em> or <em>FGG</em>&nbsp;gene, the respective subunit is not made and the fibrinogen protein cannot be assembled. This results in the absence of fibrin, so blood clots cannot form, leading to the excessive bleeding seen in people with afibrinogenemia.[11607]<br />","dateModified":"2016-05-30T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":1413,"authors":"Chen YB, Zieve D","articleTitle":"Congenital afibrinogenemia","bookWebsiteJournalTitle":"MedlinePlus","date":"January 27, 2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001313.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1414,"authors":"","articleTitle":"Afibrinogenemia, Congenital","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2007","volume":"","pages":"","url":"http://rarediseases.org/rare-diseases/afibrinogenemia-congenital/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1415,"authors":"Acharya SS","articleTitle":"Inherited Abnormalities of Fibrinogen","bookWebsiteJournalTitle":"Medscape Reference","date":"November 18, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/960677-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1416,"authors":"","articleTitle":"Afibrinogenemia, Congenital","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man (OMIM)","date":"September 22, 2014","volume":"","pages":"","url":"http://omim.org/entry/202400","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11607,"authors":"","articleTitle":"Congenital afibrinogenemia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"September 2014","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/congenital-afibrinogenemia","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2292,"questionText":"Is afibrinogenemia an inherited condition?","answerText":"Afibrinogenemia is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner, meaning that&nbsp;in order to be affected, an individual must have inherited two abnormal genes, one from each parent.[1413][1414][1415][11607] The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene. Individuals with just one mutated gene are called carriers and have about half of the normal level of fibrinogen in their blood. They typically don't show signs or symptoms of the condition.[11607] When 2 carriers of an autosomal recessive condition have children, each child has a:<br />\r\n<ul>\r\n    <li>25% (1 in 4) chance to be affected,</li>\r\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent,</li>\r\n    <li>25% (1 in 4) chance to be unaffected <em>and</em> not be a carrier.</li>\r\n</ul>\r\n&nbsp;","dateModified":"2016-05-31T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":1413,"authors":"Chen YB, Zieve D","articleTitle":"Congenital afibrinogenemia","bookWebsiteJournalTitle":"MedlinePlus","date":"January 27, 2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001313.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1414,"authors":"","articleTitle":"Afibrinogenemia, Congenital","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2007","volume":"","pages":"","url":"http://rarediseases.org/rare-diseases/afibrinogenemia-congenital/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1415,"authors":"Acharya SS","articleTitle":"Inherited Abnormalities of Fibrinogen","bookWebsiteJournalTitle":"Medscape Reference","date":"November 18, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/960677-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11607,"authors":"","articleTitle":"Congenital afibrinogenemia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"September 2014","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/congenital-afibrinogenemia","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2294,"questionText":"How might afibrinogenemia be treated?","answerText":"There is no known prevention or cure for afibrinogenemia.[1413]&nbsp;<span class=\"minusOne\">To treat bleeding episodes or to prepare for surgery to treat other conditions, patients may receive:[1413][1415]</span>\r\n<ul>\r\n    <li>Cryoprecipitate (a blood product containing concentrated fibrinogen and other clotting factors)</li>\r\n    <li>The liquid portion of the blood containing clotting factors (plasma)</li>\r\n    <li>Fibrinogen concentrates</li>\r\n</ul>\r\n<p>Prophylactic therapy should also be considered for patients with recurrent bleeding episodes, CNS hemorrhage, or during pregnancy for women with recurrent miscarriage.[1415]</p>\r\n<p>Individuals with afibrinogenemia should consider the following as part of their management plan:</p>\r\n<ul>\r\n    <li>Consultation with a hematologist/hemostasis specialist, particularly&nbsp;for patients who require fibrinogen replacement therapy.[1415]</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/geneticcounseling.html\" target=\"_blank\">Genetic counseling</a> and family studies, especially for individuals with extensive family history or those considering pregnancy.[1415]</li>\r\n    <li>Follow-up&nbsp;by a comprehensive bleeding disorder care team experienced in diagnosing and managing inherited bleeding disorders.[1415]</li>\r\n    <li>Vaccination with&nbsp;the <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/007613.htm\" target=\"_blank\">hepatitis B vaccine</a> because transfusion increases the risk of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001154.htm\" target=\"_blank\">hepatitis</a>.[1413]</li>\r\n</ul>\r\n<br />\r\n<br />","dateModified":"2016-05-31T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1413,"authors":"Chen YB, Zieve D","articleTitle":"Congenital afibrinogenemia","bookWebsiteJournalTitle":"MedlinePlus","date":"January 27, 2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001313.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1415,"authors":"Acharya SS","articleTitle":"Inherited Abnormalities of Fibrinogen","bookWebsiteJournalTitle":"Medscape Reference","date":"November 18, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/960677-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2295,"questionText":"What is the average lifespan for individuals with afibrinogenemia?","answerText":"Although we were not able to find data regarding the life expectancy for individuals with afibrinogenemia, excessive&nbsp;bleeding is common with this condition. These episodes may be severe, or even fatal.[1413]&nbsp;Bleeding in the brain is a leading cause of death in patients with this disorder.[1413][1415] Postoperative bleeding is also commonly associated with mortality in this condition.[1415]<br />\r\n<br />","dateModified":"2016-05-31T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":1413,"authors":"Chen YB, Zieve D","articleTitle":"Congenital afibrinogenemia","bookWebsiteJournalTitle":"MedlinePlus","date":"January 27, 2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001313.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1415,"authors":"Acharya SS","articleTitle":"Inherited Abnormalities of Fibrinogen","bookWebsiteJournalTitle":"Medscape Reference","date":"November 18, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/960677-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10720,"questionText":"How rare is afibrinogenemia?","answerText":"Afibrinogenemia occurs in approximately 1 in 1 million people.[1415][11607][11618] <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26407137\" target=\"_blank\">Abolghasemi and Shahverdi (2015)</a> mention that there have been about 250 cases of afibrinogenemia reported in the world literature.[11619] You can access general information about the frequency of inherited fibrinogen disorders and other rare bleeding disorders through the <a href=\"http://www.rarecoagulationdisorders.org/diseases/rare-congenital-fibrinogen-deficiencies/disease-overview\" target=\"_blank\">Rare Coagulation Disorders Resource Room</a>.","dateModified":"2016-05-31T17:54:00","resourceClassificationName":"Statistics","references":[{"referenceId":1415,"authors":"Acharya SS","articleTitle":"Inherited Abnormalities of Fibrinogen","bookWebsiteJournalTitle":"Medscape Reference","date":"November 18, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/960677-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11607,"authors":"","articleTitle":"Congenital afibrinogenemia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"September 2014","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/congenital-afibrinogenemia","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11618,"authors":"","articleTitle":"Familial afibrinogenemia","bookWebsiteJournalTitle":"Orphanet","date":"October 2009","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98880","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11619,"authors":"Abolghasemi H, Shahverdi E","articleTitle":"Umbilical bleeding: a presenting feature for congenital afibrinogenemia.","bookWebsiteJournalTitle":"Blood Coagul Fibrinolysis","date":"2015 Oct","volume":"26(7)","pages":"834-5","url":"https://www.ncbi.nlm.nih.gov/pubmed/26407137","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":56764,"abbreviatedInquiry":"How rare is this condition, How many cases are in the USA?","caseQuestions":[{"questionId":10720,"questionText":"How rare is afibrinogenemia?","answerText":"Afibrinogenemia occurs in approximately 1 in 1 million people.[1415][11607][11618] <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26407137\" target=\"_blank\">Abolghasemi and Shahverdi (2015)</a> mention that there have been about 250 cases of afibrinogenemia reported in the world literature.[11619] You can access general information about the frequency of inherited fibrinogen disorders and other rare bleeding disorders through the <a href=\"http://www.rarecoagulationdisorders.org/diseases/rare-congenital-fibrinogen-deficiencies/disease-overview\" target=\"_blank\">Rare Coagulation Disorders Resource Room</a>.","dateModified":"2016-05-31T17:54:00","resourceClassificationName":"Statistics","references":[{"referenceId":1415,"authors":"Acharya SS","articleTitle":"Inherited Abnormalities of Fibrinogen","bookWebsiteJournalTitle":"Medscape Reference","date":"November 18, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/960677-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11607,"authors":"","articleTitle":"Congenital afibrinogenemia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"September 2014","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/congenital-afibrinogenemia","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11618,"authors":"","articleTitle":"Familial afibrinogenemia","bookWebsiteJournalTitle":"Orphanet","date":"October 2009","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98880","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11619,"authors":"Abolghasemi H, Shahverdi E","articleTitle":"Umbilical bleeding: a presenting feature for congenital afibrinogenemia.","bookWebsiteJournalTitle":"Blood Coagul Fibrinolysis","date":"2015 Oct","volume":"26(7)","pages":"834-5","url":"https://www.ncbi.nlm.nih.gov/pubmed/26407137","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":5714,"phenoTypeName":"Epistaxis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9809,"phenoTypeName":"Gingival bleeding","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5682,"phenoTypeName":"Joint swelling","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1153,"phenoTypeName":"Menometrorrhagia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6100,"phenoTypeName":"Spontaneous abortion","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10646,"phenoTypeName":"Cerebral hemorrhage","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15531,"phenoTypeName":"Abnormal bleeding","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":1548,"phenoTypeName":"Hypofibrinogenemia","percentRanges":"-"},{"phenoTypeId":6272,"phenoTypeName":"Splenic rupture","percentRanges":"-"}],"medicalProducts":[{"productId":772,"genericName":"Human fibrinogen","tradeName":"FIBRYGA","tradeLink":"https://www.fibrygausa.com/","manufacturer":"","sponsor":"Octapharma","indication":"FIBRYGA is a human fibrinogen concentrate indicated for the treatment of acute bleeding episodes in adults and adolescents with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.\r\n\r\nFIBRYGA is not indicated for dysfibrinogenemia.","drugInformationLink":"","medlinePlusLink":""},{"productId":135,"genericName":"Human fibrinogen concentrate, pasteurized","tradeName":"RiaSTAPÂ®","tradeLink":"http://www.riastap.com/professional/default.aspx","manufacturer":"","sponsor":"CSL Behring, LLC","indication":"Treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency (afibrinogenemia and hypofibrinogenemia).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/RiaSTAP","medlinePlusLink":""}],"EncodedName":"Afibrinogenemia"}